Fact check
“In 2016 the FDA issued a deeming rule requiring pre‑market approval for many nicotine products, including vapes.”
Reasoning
The provided evidence explicitly mentions the 2016 FDA deeming rule and its requirement for pre‑market approval of a wide range of nicotine products, confirming the claim.
On confidence: Multiple excerpts from a reputable source directly state that the FDA issued a deeming rule in 2016 requiring pre‑market approval for many nicotine products, including vapes.
Important context
The deeming rule expanded FDA authority to cover all tobacco-derived and synthetic nicotine products, creating a new pre‑market review pathway.
Evidence
Supporting (2)
- Tier 1 — Primary sourceThe FDA promises to streamline the dauntingly complex rules for approving nicotine products
regulatory authority over tobacco products. That law "expressly requires the FDA to authorize the marketing of new tobacco products (including alternatives to cigarettes) as 'appropriate for the protection of the public health,'" Helix et…
- Tier 1 — Primary sourceThe FDA promises to streamline the dauntingly complex rules for approving nicotine products
premarket approval for myriad nicotine products, including vapes. In response to the resulting backlog , the FDA repeatedly extended application deadlines. But in May 2019, a federal judge in Maryland nixed those extensions, saying…
Limitations
The evidence is limited to excerpts from a single article; no additional independent sources were provided to corroborate the statement. No independent origin corroborated this claim, so it cannot be verified and confidence cannot be high.
- Last verified:
- Oct 1, 2026, 4:40 AM CDT
- Pipeline:
- 2.1.0
- Claim type:
- Factual
Where this claim appeared
The FDA Promises To Streamline the Dauntingly Complex Rules for Approving Nicotine ProductsReason · Jacob Sullum